IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lutty, G. A.
Right arrow Articles by Nagel, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lutty, G. A.
Right arrow Articles by Nagel, R. L.
(Investigative Ophthalmology and Visual Science. 2001;42:1349-1355.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Inhibition of TNF-{alpha}–induced Sickle RBC Retention in Retina by a VLA-4 Antagonist

Gerard A. Lutty1, Makoto Taomoto1, Jingtai Cao1, D. Scott McLeod1, Peter Vanderslice2, Brad W. McIntyre3, Mary E. Fabry4 and Ronald L. Nagel4

1 From the Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, Maryland; 2 Texas Biotechnology Corp., Houston, Texas; 3 Department of Immunology, University of Texas, Houston; and 4 Division of Hematology, Albert Einstein College of Medicine, Bronx, New York.

PURPOSE. Patients with sickle cell disease have elevated circulating levels of cytokines including tumor necrosis factor (TNF) {alpha}. TNF-{alpha} stimulates expression by endothelial cells of adhesion molecules, including vascular cell adhesion molecule (VCAM) 1. Others have demonstrated that VLA-4 ({alpha}4ß1), a ligand for VCAM-1 or fibronectin, is present on a fraction of sickle reticulocytes. The intent of this study was to determine, using a rat model, if TNF-{alpha} increases retention of sickle erythrocytes in retina and if that retention can be inhibited.

METHODS. TNF-{alpha} was given intraperitoneally to rats 5 hours before IV administration of FITC-labeled, density-separated sickle erythrocytes. After 5 minutes, rats were exsanguinated, and retinas were excised and incubated for ADPase activity, permitting the determination of the number and location of retained cells.

RESULTS. TNF-{alpha} caused a three- to fourfold increase in retention of sickle erythrocytes in retinal capillaries (P < 0.05) but not of normal human erythrocytes. Preincubation of sickle erythrocytes with TBC772, a peptide that blocks the binding of {alpha}4ß1 and {alpha}4ß7, or a monoclonal antibody against VLA-4 (19H8), significantly inhibited the TNF-{alpha}–induced retention (P <= 0.02), whereas a control cyclic peptide and antibody had no effect. IV TBC772 also inhibited sickle erythrocyte retention (P = 0.01). Two intravenously administered anti-fibronectin antibodies inhibited sickle cell retention as well, but an anti-rat VCAM-1 antibody did not inhibit retention.

CONCLUSIONS. The authors conclude that TNF-{alpha} stimulates retention of sickle erythrocytes in the retinal vasculature. This increased retention can be blocked by a VLA-4 antagonist, suggesting that the cells retained after cytokine stimulation are reticulocytes. The counter-receptor for VLA-4 in this rat retina model appears to be fibronectin and not VCAM-1, based on data obtained using antibodies against these molecules.




This article has been cited by other articles:


Home page
ASH Education BookHome page
M. J. Telen
Role of Adhesion Molecules and Vascular Endothelium in the Pathogenesis of Sickle Cell Disease
Hematology, January 1, 2007; 2007(1): 84 - 90.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. G. Woodside, R. M. Kram, J. S. Mitchell, T. Belsom, M. J. Billard, B. W. McIntyre, and P. Vanderslice
Contrasting Roles for Domain 4 of VCAM-1 in the Regulation of Cell Adhesion and Soluble VCAM-1 Binding to Integrin {alpha}4beta1.
J. Immunol., April 15, 2006; 176(8): 5041 - 5049.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. H. Embury, N. M. Matsui, S. Ramanujam, T. N. Mayadas, C. T. Noguchi, B. A. Diwan, N. Mohandas, and A. T. W. Cheung
The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo
Blood, November 15, 2004; 104(10): 3378 - 3385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. D. Holtzclaw, D. Jack, S. M. Aguayo, J. R. Eckman, J. Roman, and L. L. Hsu
Enhanced Pulmonary and Systemic Response to Endotoxin in Transgenic Sickle Mice
Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 687 - 695.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Wei, J. M. Runnels, and C. P. Lin
Selective Uptake of Indocyanine Green by Reticulocytes in Circulation
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4489 - 4496.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. M. Matsui, A. Varki, and S. H. Embury
Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin
Blood, November 15, 2002; 100(10): 3790 - 3796.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M K. Mathews, D S McLeod, C Merges, J Cao, and G A Lutty
Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy
Br. J. Ophthalmol., June 1, 2002; 86(6): 684 - 690.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology